Navigation Links
Kendle Advances Early Stage Drug Development with ElMindA's Innovative Brain Network Activation Technology
Date:6/15/2010

lers.

BNA technology is available immediately to Kendle customers through the Company's early stage units in Toronto, Canada and Utrecht, The Netherlands.  Kendle is a worldwide leader in early stage clinical development, providing high-end scientific exploratory/translational medicine expertise from first-in-human studies through Phase IIa/proof-of-concept. The Company offers unrivalled expertise in the conduct of studies involving the measurement of pharmacodynamic parameters, particularly in drugs acting on the Central Nervous System. Kendle's early stage core competencies include neurocognitive assessment, abuse liability assessment and pharmacogenomics. The Company's offerings also include bioequivalence and bioavailability services for customers in the generics industry.

About ElMindA

ElMindA Ltd. develops and markets a non-invasive, diagnosis and treatment management platform that addresses a critical unmet need in neurological and psychiatric disorders to dramatically enhance treatment efficacy and patients' quality of life while reducing costs. ElMindA's mission is to revolutionize the treatment of brain-related pathologies by revealing, for the first time ever, the dynamic electrophysiological neural network connectivity and synchronization of the brain, paving the way to affecting brain plasticity and empowering the dramatic improvement of brain disorder treatment at any neurological and psychiatric point of care. ElMindA's platform can be utilized for a wide range of neurological and psychiatric applications and is currently available for clinical development. ElMindA is located at 16 Haminhara St., Beit Bachar Herzliya 46586, Israel. For more information visit

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Kendle Director of Global Safety and Pharmacovigilance, Drew Kilpatrick, PhD, Named One of Ten Notable People in R&D
2. Kendle Executive to Share Insights at World Pharma Trials Asia 2010
3. Kendle is First Global CRO to Achieve ISO 9001:2008 Certification in China Through Beijing Affiliate
4. Kendle Launches New Global Biostatistics Infrastructure
5. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
6. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
7. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
8. Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
9. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
10. Simulated Surgical Systems, LLC Partners to Bring Simulation Advances to Surgical Training
11. Gamma Knife Users Share Latest Advances for Treating Cancer, Other Brain Disorders at Society Meeting in Greece
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, ... the Journal of Drugs in Dermatology (JDD) ... (ODAC). The event is January 17-20, 2014, at the Omni Orlando ... The ODAC is a distinguished event ...
(Date:1/15/2014)... Jan. 15, 2014  In an unprecedented effort to curb the spread ... and other transport vehicles, an advanced and portable UV germicidal lamp ... the first time. In order to prevent EMS ... pathogens, West Palm Beach Fire Rescue is ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading ... to release its second quarter 2011 financial results on Tuesday, ... financial markets.  The Company will also host a conference call ... 2011 to discuss its financial results and provide an update ...
... CHADDS FORD, Pa., June 30, 2011 Endo Pharmaceuticals (Nasdaq: ... phase 2 study comparing the novel investigational drug axomadol against ... chronic low back pain. The results indicate that axomadol did ... completing additional analyses of the data and evaluating the path ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss Second Quarter 2011 Earnings 2Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2
(Date:4/17/2014)... 17, 2014) Two recent papers by a ... colleagues may help scientists develop treatments or vaccines ... Japanese encephalitis and other disease-causing flaviviruses. , Jeffrey ... molecular genetics at the School of Medicine and ... Medical Institute, and colleagues recently published articles in ...
(Date:4/17/2014)... Le Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, ... the April issue of Nature Reviews Microbiology ... Dr. McCullers, a world-renowned infectious disease specialist, ... the University of Tennessee Health Science Center, analyzed ... 1918, 1957 and 1968 pandemics, as well as ...
(Date:4/17/2014)... military personnel who served in Iraq and Afghanistan ... injury (TBI) were compared to military personnel without ... Differences in measures of overall disability, cognitive function, ... are reported in an article in Journal ... Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... love and addiction may go hand in hand due ... as a result of dopamine release// (neurotransmitter) after having ... of the effects observed following drug abuse with cocaine ... leaves the user with an insatiable feeling, probing for ...
... Cardiac rehabilitation program with safe and tolerable exercise can ... which help them to have a better heart function//. ... the supervision of Cardiologist, Jonathan Rhodes. ,The ... group of 8 to 17 with severe congenital heart ...
... the coffee cap proposed by a study by Florian Koppelstatter, ... cup of coffee with 100 mg caffeine can boost short-term ... 15 healthy men aged 26 to 47. Participants were tested ... consumed a placebo. 100 mg caffeine can be found in ...
... Austrian researchers at the annual meeting of the Radiological ... that caffeine has the ability to boost short-term memory// ... control this activity. ,Caffeine is normally found ... chocolate. The researchers tested 15 subjects who had just ...
... called Sonam was born with a hearing in both ears in ... completing her first year as result of a successful cochlear implant ... shortcoming when she was three months old. But they did not ... down the line, she behaves like any other normal child. ...
... Bill Gates, Chief of Microsoft, will visit India on 6 ... will be among the cities he will visit as he ... India//. ,India figures very high on the priority list ... him sharing his IT vision as he interacts with key ...
Cached Medicine News:Health News:Love And Drug Addiction Share The Same Chemistry 2Health News:Early Intervention Required For The Hearing Impaired 2Health News:Bill Gates Takes Personal Interest in AIDS Program 2
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
BioVintages Biotin-Trapper™ Streptavidin Magnetic Beads (1 mm - 2 mm) are designed for single-step capture of biotinylated molecules such as DNA, RNA or protein from cell lysates or hybridizatio...
... is a method for isolating antibodies, ... cells using affinity binding, while retaining ... on the particles to separate biotinylated ... the MagnaBind™ Beads from the suspension, ...
... m Dynabeads with covalently bound ... any biotinylated target. The Dynabeads® ... area, high capacity, magnetic pull ... during incubation. The MyOne™ products ...
Medicine Products: